Clinical Trial Update: VEGF In Systemic Circulation Of ROP-infants

View source ↗

Summary

A clinical trial studying VEGF in the systemic circulation of infants with retinopathy of prematurity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: University Hospital Freiburg | Conditions: Retinopathy of Prematurity (ROP) | Status: WITHDRAWN